Cargando…
Extensive sequence and structural evolution of Arginase 2 inhibitory antibodies enabled by an unbiased approach to affinity maturation
Affinity maturation is a powerful technique in antibody engineering for the in vitro evolution of antigen binding interactions. Key to the success of this process is the expansion of sequence and combinatorial diversity to increase the structural repertoire from which superior binding variants may b...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382286/ https://www.ncbi.nlm.nih.gov/pubmed/32616569 http://dx.doi.org/10.1073/pnas.1919565117 |
_version_ | 1783563215945334784 |
---|---|
author | Chan, Denice T. Y. Jenkinson, Lesley Haynes, Stuart W. Austin, Mark Diamandakis, Agata Burschowsky, Daniel Seewooruthun, Chitra Addyman, Alexandra Fiedler, Sebastian Ryman, Stephanie Whitehouse, Jessica Slater, Louise H. Gowans, Ellen Shibata, Yoko Barnard, Michelle Wilkinson, Robert W. Vaughan, Tristan J. Holt, Sarah V. Cerundolo, Vincenzo Carr, Mark D. Groves, Maria A. T. |
author_facet | Chan, Denice T. Y. Jenkinson, Lesley Haynes, Stuart W. Austin, Mark Diamandakis, Agata Burschowsky, Daniel Seewooruthun, Chitra Addyman, Alexandra Fiedler, Sebastian Ryman, Stephanie Whitehouse, Jessica Slater, Louise H. Gowans, Ellen Shibata, Yoko Barnard, Michelle Wilkinson, Robert W. Vaughan, Tristan J. Holt, Sarah V. Cerundolo, Vincenzo Carr, Mark D. Groves, Maria A. T. |
author_sort | Chan, Denice T. Y. |
collection | PubMed |
description | Affinity maturation is a powerful technique in antibody engineering for the in vitro evolution of antigen binding interactions. Key to the success of this process is the expansion of sequence and combinatorial diversity to increase the structural repertoire from which superior binding variants may be selected. However, conventional strategies are often restrictive and only focus on small regions of the antibody at a time. In this study, we used a method that combined antibody chain shuffling and a staggered-extension process to produce unbiased libraries, which recombined beneficial mutations from all six complementarity-determining regions (CDRs) in the affinity maturation of an inhibitory antibody to Arginase 2 (ARG2). We made use of the vast display capacity of ribosome display to accommodate the sequence space required for the diverse library builds. Further diversity was introduced through pool maturation to optimize seven leads of interest simultaneously. This resulted in antibodies with substantial improvements in binding properties and inhibition potency. The extensive sequence changes resulting from this approach were translated into striking structural changes for parent and affinity-matured antibodies bound to ARG2, with a large reorientation of the binding paratope facilitating increases in contact surface and shape complementarity to the antigen. The considerable gains in therapeutic properties seen from extensive sequence and structural evolution of the parent ARG2 inhibitory antibody clearly illustrate the advantages of the unbiased approach developed, which was key to the identification of high-affinity antibodies with the desired inhibitory potency and specificity. |
format | Online Article Text |
id | pubmed-7382286 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | National Academy of Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-73822862020-07-30 Extensive sequence and structural evolution of Arginase 2 inhibitory antibodies enabled by an unbiased approach to affinity maturation Chan, Denice T. Y. Jenkinson, Lesley Haynes, Stuart W. Austin, Mark Diamandakis, Agata Burschowsky, Daniel Seewooruthun, Chitra Addyman, Alexandra Fiedler, Sebastian Ryman, Stephanie Whitehouse, Jessica Slater, Louise H. Gowans, Ellen Shibata, Yoko Barnard, Michelle Wilkinson, Robert W. Vaughan, Tristan J. Holt, Sarah V. Cerundolo, Vincenzo Carr, Mark D. Groves, Maria A. T. Proc Natl Acad Sci U S A Biological Sciences Affinity maturation is a powerful technique in antibody engineering for the in vitro evolution of antigen binding interactions. Key to the success of this process is the expansion of sequence and combinatorial diversity to increase the structural repertoire from which superior binding variants may be selected. However, conventional strategies are often restrictive and only focus on small regions of the antibody at a time. In this study, we used a method that combined antibody chain shuffling and a staggered-extension process to produce unbiased libraries, which recombined beneficial mutations from all six complementarity-determining regions (CDRs) in the affinity maturation of an inhibitory antibody to Arginase 2 (ARG2). We made use of the vast display capacity of ribosome display to accommodate the sequence space required for the diverse library builds. Further diversity was introduced through pool maturation to optimize seven leads of interest simultaneously. This resulted in antibodies with substantial improvements in binding properties and inhibition potency. The extensive sequence changes resulting from this approach were translated into striking structural changes for parent and affinity-matured antibodies bound to ARG2, with a large reorientation of the binding paratope facilitating increases in contact surface and shape complementarity to the antigen. The considerable gains in therapeutic properties seen from extensive sequence and structural evolution of the parent ARG2 inhibitory antibody clearly illustrate the advantages of the unbiased approach developed, which was key to the identification of high-affinity antibodies with the desired inhibitory potency and specificity. National Academy of Sciences 2020-07-21 2020-07-02 /pmc/articles/PMC7382286/ /pubmed/32616569 http://dx.doi.org/10.1073/pnas.1919565117 Text en https://creativecommons.org/licenses/by/4.0/This open access article is distributed under Creative Commons Attribution License 4.0 (CC BY) (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Biological Sciences Chan, Denice T. Y. Jenkinson, Lesley Haynes, Stuart W. Austin, Mark Diamandakis, Agata Burschowsky, Daniel Seewooruthun, Chitra Addyman, Alexandra Fiedler, Sebastian Ryman, Stephanie Whitehouse, Jessica Slater, Louise H. Gowans, Ellen Shibata, Yoko Barnard, Michelle Wilkinson, Robert W. Vaughan, Tristan J. Holt, Sarah V. Cerundolo, Vincenzo Carr, Mark D. Groves, Maria A. T. Extensive sequence and structural evolution of Arginase 2 inhibitory antibodies enabled by an unbiased approach to affinity maturation |
title | Extensive sequence and structural evolution of Arginase 2 inhibitory antibodies enabled by an unbiased approach to affinity maturation |
title_full | Extensive sequence and structural evolution of Arginase 2 inhibitory antibodies enabled by an unbiased approach to affinity maturation |
title_fullStr | Extensive sequence and structural evolution of Arginase 2 inhibitory antibodies enabled by an unbiased approach to affinity maturation |
title_full_unstemmed | Extensive sequence and structural evolution of Arginase 2 inhibitory antibodies enabled by an unbiased approach to affinity maturation |
title_short | Extensive sequence and structural evolution of Arginase 2 inhibitory antibodies enabled by an unbiased approach to affinity maturation |
title_sort | extensive sequence and structural evolution of arginase 2 inhibitory antibodies enabled by an unbiased approach to affinity maturation |
topic | Biological Sciences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382286/ https://www.ncbi.nlm.nih.gov/pubmed/32616569 http://dx.doi.org/10.1073/pnas.1919565117 |
work_keys_str_mv | AT chandenicety extensivesequenceandstructuralevolutionofarginase2inhibitoryantibodiesenabledbyanunbiasedapproachtoaffinitymaturation AT jenkinsonlesley extensivesequenceandstructuralevolutionofarginase2inhibitoryantibodiesenabledbyanunbiasedapproachtoaffinitymaturation AT haynesstuartw extensivesequenceandstructuralevolutionofarginase2inhibitoryantibodiesenabledbyanunbiasedapproachtoaffinitymaturation AT austinmark extensivesequenceandstructuralevolutionofarginase2inhibitoryantibodiesenabledbyanunbiasedapproachtoaffinitymaturation AT diamandakisagata extensivesequenceandstructuralevolutionofarginase2inhibitoryantibodiesenabledbyanunbiasedapproachtoaffinitymaturation AT burschowskydaniel extensivesequenceandstructuralevolutionofarginase2inhibitoryantibodiesenabledbyanunbiasedapproachtoaffinitymaturation AT seewooruthunchitra extensivesequenceandstructuralevolutionofarginase2inhibitoryantibodiesenabledbyanunbiasedapproachtoaffinitymaturation AT addymanalexandra extensivesequenceandstructuralevolutionofarginase2inhibitoryantibodiesenabledbyanunbiasedapproachtoaffinitymaturation AT fiedlersebastian extensivesequenceandstructuralevolutionofarginase2inhibitoryantibodiesenabledbyanunbiasedapproachtoaffinitymaturation AT rymanstephanie extensivesequenceandstructuralevolutionofarginase2inhibitoryantibodiesenabledbyanunbiasedapproachtoaffinitymaturation AT whitehousejessica extensivesequenceandstructuralevolutionofarginase2inhibitoryantibodiesenabledbyanunbiasedapproachtoaffinitymaturation AT slaterlouiseh extensivesequenceandstructuralevolutionofarginase2inhibitoryantibodiesenabledbyanunbiasedapproachtoaffinitymaturation AT gowansellen extensivesequenceandstructuralevolutionofarginase2inhibitoryantibodiesenabledbyanunbiasedapproachtoaffinitymaturation AT shibatayoko extensivesequenceandstructuralevolutionofarginase2inhibitoryantibodiesenabledbyanunbiasedapproachtoaffinitymaturation AT barnardmichelle extensivesequenceandstructuralevolutionofarginase2inhibitoryantibodiesenabledbyanunbiasedapproachtoaffinitymaturation AT wilkinsonrobertw extensivesequenceandstructuralevolutionofarginase2inhibitoryantibodiesenabledbyanunbiasedapproachtoaffinitymaturation AT vaughantristanj extensivesequenceandstructuralevolutionofarginase2inhibitoryantibodiesenabledbyanunbiasedapproachtoaffinitymaturation AT holtsarahv extensivesequenceandstructuralevolutionofarginase2inhibitoryantibodiesenabledbyanunbiasedapproachtoaffinitymaturation AT cerundolovincenzo extensivesequenceandstructuralevolutionofarginase2inhibitoryantibodiesenabledbyanunbiasedapproachtoaffinitymaturation AT carrmarkd extensivesequenceandstructuralevolutionofarginase2inhibitoryantibodiesenabledbyanunbiasedapproachtoaffinitymaturation AT grovesmariaat extensivesequenceandstructuralevolutionofarginase2inhibitoryantibodiesenabledbyanunbiasedapproachtoaffinitymaturation |